| Murenzi, Gad |
Research For Development
United States |
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention |
1UG1CA284908-01 |
|
Silvina Frech, Ph.D., M.S. |
| Murphy, Elizabeth Angela |
University Of South Carolina At Columbia
United States |
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer - admin supplement |
3U01CA272977-02S1 |
|
|
| Mustian, Karen M. |
University Of Rochester
United States |
Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice |
3UG1CA189961-10S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Mwesigwa, Betty |
Makerere University Walter Reed Project
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) |
5UG1CA275412-02 |
|
Silvina Frech, Ph.D., M.S. |
| Naicker, Nivashnee |
Centre/Aids Programme/Res/South Africa
United States |
CAPRISA CASCADE Clinical Trials Network Clinical Research Site |
1UG1CA284671-01 |
|
Silvina Frech, Ph.D., M.S. |
| Nappi, Lucia |
Provincial Health Services Authority
United States |
Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. |
5R37CA264798-02 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
| Nath, Kavindra |
University Of Pennsylvania
United States |
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition |
5R01CA228457-05 |
|
|
| Nathan, Cherie-Ann O |
Louisiana State Univ Hsc Shreveport
United States |
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma. |
5R01CA217180-05 |
|
Howard L. Parnes, M.D. |
| Nautiyal, Shivani |
Prime Genomics, Inc.
United States |
Device for Preservation of Cell Free RNA in Saliva |
5R21CA258013-02 |
|
Guillermo Marquez, Ph.D. |
| Nechiporuk, Alex |
Oregon Health & Science University
United States |
High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. |
1R21CA260025-01A1 |
|
Rachel Altshuler, Ph.D. |